Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a hoped-for intervention to reduce nonadherence to psychotropic medications due to metabolic syndrome and, potentially, to reduce metabolic syndrome-related premature cardiovascular death among those un... ...

请注册登录后继续浏览